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Abstract
Protocols in the academic life science laboratory are heavily reliant on the manual manipulation of 
tools, reagents and instruments by a host of research staff and students. In contrast to industrial and 
clinical laboratory environments, the usage of automation to augment or replace manual tasks is 
limited. Causes of this 'automation gap' are unique to academic research, with rigid short-term 
funding structures, high levels of protocol variability and a benevolent culture of investment in 
people over equipment. Automation, however, can bestow multiple benefits through improvements in
reproducibility, researcher efficiency, clinical translation, and safety. Less immediately obvious are 
the accompanying limitations, including obsolescence and an inhibitory effect on the freedom to 
innovate. Growing the range of automation options suitable for research laboratories will require 
more flexible, modular and cheaper designs. Academic and commercial developers of automation 
will increasingly need to design with an environmental awareness and an understanding that large 
high-tech robotic solutions may not be appropriate for laboratories with constrained financial and 
spatial resources. To fully exploit the potential of laboratory automation, future generations of 
scientists will require both engineering and biology skills. Automation in the research laboratory is 
likely to be an increasingly critical component of future research programs and will continue the 
trend of combining engineering and science expertise together to answer novel research questions.
1 Introduction
The progressive integration of automation into work environments has enhanced the production rates,
efficiency and quality of an enormous array of industrial processes (Hitomi 1994; Autor 2015). From 
generation to generation, mechanised tooling has replaced swathes of manual tasks. More recent 
advances in robotics and information technology have further automated processes that were once the
sole domain of human brawn or brain (Hasegawa 2009). Life science research conducted within 
academic institutions has also welcomed the ingress of mechanised equipment designed to automate 
a range of tasks. However, it is noticeable that a typical university research laboratory, often led by a 
single principal investigator, maintains a high level of manual manipulation in the form of 
undergraduate, postgraduate, post-doctoral and technical staff. Many experimental procedures remain
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This is in contrast to industrial environments, where widespread investment in automation has 
allowed companies to maximise their outputs and increase profits (Ravazzi and Villa 2009). 
Laboratories in a clinical setting have also experienced the benefits of adopting automation (Hawker 
et al. 2017), increasing the speed and reliability of patient-specific data for use by clinicians (Lou et 
al. 2016; Sarkozi et al. 2003). In this review, written from the perspective of an automation engineer 
now working in synthetic biology research and a Principal Investigator managing a research 
laboratory, we classify the current levels of automation in laboratories and highlight the benefits and 
limitations of its usage in research. We further attempt to summarise why automation has had such a 
limited impact in our workplace (Jessop-Fabre and Sonnenschein 2019) and ask whether the solution 
to including more automation into everyday laboratory tasks may reside in greater communication 
between scientists and engineers. Further, we suggest that it could be accelerated by beginning with a
more low-tech approach rather than striving too soon for fully autonomous systems.
2 Current laboratory automation
Well-meaning predictions of the cybernetic laboratory (Beugelsdijk 1991) and a robotic revolution 
(Boyd 2002) have, at the time of writing, yet to materialise in the majority of life science research 
laboratories. Evidence from the proportional use of the terms “automation” or “automated” in the 
titles of PubMed listed articles does, however, exhibit a steady increase over the previous 4 decades. 
The terms “robot” or “robotic”, which are often used interchangeably with automation, received 
negligible use until the mid 90’s and then showed a more marked elevation (Figure 1). It should be 
noted however that, “robot” or “robotic” can also be used as an adjective for biological systems or 
medical devices and the increase in their prevalence may represent changes in language usage rather 
than an indication of greater automation usage. A more thorough text mining exercise than ours 
attempted to measure the extent of manual protocols that could potentially be automated through 
analysis of methods sections in published life science articles. The study concluded that 89% of 
articles featured a manual protocol that has an automated alternative (Groth and Cox 2017). Whilst 
there is a scale of automation, from the simple to the complex, that could be applied to these 
protocols, such data provides evidence that there remains a large potential for automation in most 
biology research laboratories. There are also clear claims in the literature that researchers working in 
academic institutions have been slow to embrace automation (Jessop-Fabre and Sonnenschein 2019; 
De Almeida and Ferreira 2017; Sadowski et al. 2016).
In this review we focus on automation where it describes equipment that physically manipulates 
items and we do not consider solely software-based technologies, such as image analysis and data 
mining tools. Within our scope there resides a diverse range of equipment that is found in research 
laboratories, from simple hand tools to entirely autonomous systems. A classification system for 
laboratory automation equipment has, to our knowledge, yet to be published, although a number of 
equivalent methods have been developed for classifying industrial automation. Frohm et al, reviewed 
these systems before proposing their own 7 levels of automation (Frohm et al. 2008). These levels 
and descriptions are displayed in table 1, alongside examples typically seen in an academic research 











































It is noticeable from table 1 that the majority of equipment items that researchers would consider as 
the most expensive in their laboratory are categorised at level 5. Higher grade 6 and 7 items are a 
rarity in a biological research laboratory. Whilst mid-range level 5 automation items undoubtably 
increase the efficiency of laboratory research, they are designed for specific subtasks in a range of 
protocols. These items also generally require a large amount of manual manipulation both before and 
after machine usage. Within the research laboratory this category of equipment is commonplace and 
dominates equipment budgets. A further observation can be made in that the majority of research 
equipment in this category performs tasks that human operators would otherwise be incapable of 
carrying out themselves (McClymont and Freemont 2017). The rotation of samples at high speeds 
and observing microscale environments are examples of tasks that would be impossible without the 
use of centrifugation and microscopy equipment. Automation equipment which replaces manual 
handling tasks is rarer, and it the prevalence of these items where academic bioresearch facilities 
differ to industrial environments and clinical laboratories.
Access to high level 7 automated equipment can usually only be obtained through a pooled resource 
shared between across the parent organisation or wider research community; these are often referred 
to as biofoundries (Chambers et al. 2016; Chao et al. 2017; Kitney et al. 2019).  A new automation 
variant of the commercial contract research organisation has also arisen recently, the cloud lab. These
provide researchers with remote access to heavily automated protocols available as a pay-per-
experiment service (Hayden 2014). Cloud lab executives have made grand predictions regarding the 
impact these facilities will have on the future of biological research (Segal 2019; Miles and Lee 
2018), although doubts remain regarding experimental flexibility and the resulting inhibitory effect 
on experimental innovation (Hayden 2014).
3 Benefits of laboratory automation
3.1 Reproducibility
There are multiple advantages and limitations in including automation into scientific processes and 
these are summarised in figure 2. Most pertinent is its use in improving the reproducibility of 
laboratory research (Kitney et al. 2019). Reproducibility is a major concern for the research 
community both now (Baker 2016; Begley and Ioannidis 2015) and historically (reviewed by Fanelli 
2018), with associated economic implications (Freedman, Cockburn, and Simcoe 2015) and an 
undermining of public trust in science (Saltelli and Funtowicz 2017). Debate continues regarding the 
definition and scope of the reproducibility issue (Goodman, Fanelli, and Ioannidis 2018; Casadevall 
and Fang 2010), alongside proposed improvements in scientific practices (Munafò et al. 2017; Peng 
2015) and remedial technologies (Benchoufi and Ravaud 2017). Increasing the use of automation 
throughout research laboratories is one such proposition (Jessop-Fabre and Sonnenschein 2019; 
Kitney et al. 2019). An improvement in reproducibility is cited as a beneficial effect of automation 
implementation within clinical laboratories (Genzen et al. 2018; Hawker et al. 2017). 
Automation can assist in improving reproducibility in three ways: a reduction in human-induced 
variability, an increase in the rate of data generation, and a decrease in contamination. The 
contribution each of these factors has on increasing reproducibility depends on the individual 
protocol. Firstly, experimental variability caused by humans is an omnipresent day-to-day reality in 
research laboratories (Plebani 2010; Price et al. 2015). Variation in protocols can arise from the same
person unknowingly performing a task differently each time or between different individuals 
attempting to carry out the same procedure. Variability that is noticed at the time can be corrected for
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However, variation that goes unnoticed will manifest itself in final datasets and published results. 
Automation can replace many, but not all, of these human-based sources of variability. Mechanised 
componentry is more suited to repetitive tasks (Moutsatsou et al. 2019) in comparison to humans 
who are vulnerable to progressive mental fatigue (Xu et al. 2018), physical weariness (Iridiastadi and 
Nussbaum 2006; Björklund et al. 2000) and also distracting influences (Varao-Sousa et al. 2018). 
Laboratory protocols where manual operations have been automated demonstrate greater consistency 
in their results, improving experimental reproducibility (Klevebring et al. 2009; Price et al. 2015). 
Secondly, a greater rate of experimental data capture, with an increased volume of results, can be 
achieved with automation alongside a wider range of experimental variables tested, including 
controls. Ultimately this increases the likelihood that others will be able to reproduce and build on 
their findings (Maleki et al. 2019). Finally, there are those laboratory protocols that are susceptible to 
contamination that can arise from either from the researchers themselves (Salter et al. 2014) or 
through increased exposure to environmental contaminants due to ponderous manual handling 
operations (Greub et al. 2016). Automation can remove contact with human operators (Wilke et al. 
1995) or reduce potential contaminant exposure by lowering the required number of manual handling
steps (Mifflin, et al. 2000; Moutsatsou et al. 2019).
3.2 Laboratory efficiency
Efficiency is considered of paramount importance within manufacturing and can be defined as the 
rate of production, divided by the resources such as labour, input materials needed to accomplish this 
rate. By investing in automation, a company can increase the rate of production and also reduce the 
resources needed to achieve this rate. With a market available this can translate to a corresponding 
increase in profits (Ceroni 2009). A research laboratory investing in automation can improve the 
efficiency of its researchers (Hawker and Schlank 2000; Schneider 2018) with machinery able to 
achieve a greater rate of experimental output than a manual based alternative (Tacker et al. 2014; 
Choi et al. 2018; Price et al. 2015). It should be noted that an automated protocol need not take less 
time from start-to-finish to result in higher output than the manual alternative, as long as it demands 
less human intervention (Reed et al. 2018). This is due the to the reward for academia differing from 
industry, with efficiency considered more as a time input to experimental output ratio. The key 
benefit derived from laboratory automation driven processes is therefore in the time saved by the 
researchers; time that can be spent on other parallel experiments. Automation in most cases will 
induce a transition from manual to cognitive labour (Kaber et al. 2009). Allowing an operator to set a
protocol in operation and walk away to think and focus on other tasks is a valuable function for any 
automation equipment. Researchers frequently have multiple projects, and experimental protocols 
operating in parallel as well as an array of responsibilities beyond the laboratory. With a greater rate 
of automation-driven experimental output researchers can also identify which aspects of their 
experiments don’t work and adjust more quickly (Baranczak et al. 2017). Within industrial 
pharmaceutical development this methodology is known as fail fast, fail often (Clark and Pickett 
2000; Besteman and Bont 2019; Khanna et al. 2016). Efficiency gains can also extend to the use of 
expensive reagents and materials. Automation can provide a higher level of precision in reagent 
dispensing, reducing the amount needed per experiment.
3.3 Faster translation
Automation has an important role in those laboratories engaged in applied research who are seeking 
to develop novel therapeutic interventions such as cell-based therapies, pharmaceutical developments
or tissue-engineered constructs for implantation. Transition of these technologies from a purely 
















































2017), often referred to as translation from the bench to the bedside (Goldblatt and Lee 2010).  By 
considering and including automation at an early stage in the research process, crucial elements of 
the process can be mechanised, increasing product quality and production rates in the laboratory 
before the jump to manufacturing. The technological leap from laboratory-scale production to higher-
volume manufacturing is therefore shortened. Researchers who include automation technologies at an
early stage are subsequently better placed to upscale their processes allowing faster 
commercialisation rates and deployment to the clinic (Kotin 2011; Rafiq and Thomas 2016; 
Heathman et al. 2015).
3.4 Safety
A number of protocols carried out in the research laboratory require the handling of dangerous 
reagents and occasionally of hazardous tooling. The manual manipulation of hazardous items places 
a burden on laboratories, particularly when contending with a continual turnover of short-term 
contract staff and students who require safety training and supervision. By assigning dangerous 
handling tasks to automated machinery, the exposure of humans to hazardous substances can be 
reduced (Movsisyan et al. 2016; Caragher et al. 2017). 
3.5 Examples of automation benefits
Evidence of automation benefits can be observed in recent success stories. In scenarios where high-
throughput, reproducible results are demanded over short time frames automation has a significant 
advantage over manual based procedures. Recently a highly automated biofoundry, normally with a 
focus on research applications, was repurposed towards the development of SARS-CoV-2 assays for 
clinical diagnostics (Crone et al. 2020). Automated liquid handling equipment and was able to 
perform an extensive array of experimental procedures at a rate in excess of those that a manual 
based laboratory could carry out. Furthermore, in these time pressured experiments automation has 
an advantage over manual operators who are likely to be prone to fatigue and errors, with an 
associated negative effect on reproducibility. Such work also clearly demonstrates the positive impact
automation can have on novel public health challenges. It also an example where considerate design 
has led to systems that are flexible enough to be rapidly adapted to meet new experimental needs, 
appropriately termed “facility agility”.
The use of automation to improve research efficiency has also been shown with the publication of a 
system comprising a mobile robotic platform that can autonomously navigate a laboratory 
performing reagent dispensing and handling operations at a range of experimental benchtop stations 
(Burger et al. 2020). In combination with an artificial intelligence search algorithm the system was 
able to focus on reagent combinations deemed more likely to provide an optimum result. The 
capacity of the robotic equipment to operate at all hours, with pausing only to charge batteries, 
allowed it to ascertain answers to 5 experimental hypotheses in a fraction of the time a manual 
research team would have required. Although used to answer a research question within a chemistry 
context the concept is readily applicable to life science experimental laboratories. The system shares 
similar liquid and solid reagent handling operations to a life science laboratory as well as the 
common challenge whereby multiple variables create a research space too great for manual 
researchers to reasonably explore. A further crucial advantage of this arrangement resides in the 
capability, with appropriate safety controls, to allow a laboratory to operate as a hybrid manual-
automated laboratory, potentially with a peopled day shift followed by a robotic night shift.
The translation of stem cell derived therapies towards a clinical application has received automation 
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a scale that is beyond manual based laboratories, with large numbers also needed for research and 
clinical trials phases. The need for reliable methods of high-volume, quality assured cells has led to 
the development of automated systems such as the StemCellFactory (Doulgkeroglou et al. 2020), 
StemCellDiscovery (Jung et al. 2018) and AUTOSTEM (Ochs et al. 2017). The objective of these 
systems is to automate the normally manual stages of stem cell seeding, growth, colony selection, 
passaging, quality assessment, harvesting and potentially in later applications differentiation. In a 
similar fashion to the previous mobile robotic platform example complex control algorithms are also 
being applied to these systems with the aim of improving usable cell yields (Egri et al. 2020). These 
projects are an important link between the domains of basic life science research, clinical application 
and also commercial cell product manufacturing.  By developing these systems researchers have been
able to generate high quantities of cells for research and testing purposes, hastening the route to 
clinical usage. 
4 Limitations of automation
4.1 Incorrect application
Despite the range of benefits that laboratory automation can bring, there remains a number of 
limitations. Integrating automation into a research laboratory is not in itself a guarantee of success 
and, where applied incorrectly can even result in even less efficiency (Zielinski et al. 2014). The 
nature of automated tasks also allows for rapid propagation of errors. An example would be a 
machine incorrectly dispensing a reagent repetitively which can then, if undetected, be distributed 
across many thousands of samples. In addition, the incorrect application and operation of automation 
may not improve the reproducibility of research between laboratories. Automation machinery 
carrying out the same experimental protocol in different laboratories may still produce different 
results. This can be due to variations in input materials, different equipment models or set-up and 
calibration errors. Even where automation has been carefully integrated into a laboratory and has 
demonstrated an improvement in reproducibility an inherent machine to machine variability can 
remain. What is more, this variability can be more hidden than more easily observed manual 
procedures. Careful maintenance, calibration and quality control measures are therefore essential in 
implementing any laboratory automation system (Xie et al. 2004; Hawker and Schlank 2000).
4.2 Obsolescence
Obsolescence is an inevitability for any technology and even, it can be argued, for scientists 
themselves. Many facilities will feature a dusty machine in the corner that is unused, because 
components and materials are no-longer available, the protocol itself has been supplanted or simply 
newer more effective equipment has taken over (Croxatto et al. 2016). Predicting how and when a 
machine will become obsolete is an inherently difficult task in rapidly evolving research fields and 
can be specific to individual laboratories. Some researchers will find equipment is no-longer useful 
after a few years of operation whilst others may continue to happily use the same machine for 
decades. It is not only advances in hardware and software design that can render laboratory 
equipment obsolete. Scientific progress in reagent properties and resulting modifications to protocols 
can also be responsible. The advent of new thermostable polymerases obsoleted a whole generation 
of Polymerase Chain Reaction machinery designed upon a more repetitive protocol (Hawker et al. 
2017). Despite these difficulties, with considerate design allowing for reconfiguration and 














































referred to in some industries as future-proofing. Understanding and planning for obsolescence is 
therefore an important part of any automation strategy.
4.3 Innovation inhibition
There is a danger that automation can inhibit creativity in the experimental design process by limiting
the opportunities for changing or tinkering with a protocol. A researcher may be less inclined to alter 
a protocol to optimise it for a new situation where a large number of steps are automated. This can be
based upon the assumption that process steps carried out by machinery are already optimised and 
require no further improvement. They may also feel less able to begin changing things because they 
lack the confidence or maybe even the authorisation to open the box and begin modifying what is 
probably an expensive machine. Sharing of the machine with other users for whose purposes it is 
already optimised is also a brake to experimentation with parameters. Innovation inhibition is also a 
concern where protocols are outsourced to third party automated laboratories (Hayden 2014).
4.4 Workforce impact
When integrating new automation into any workplace environment, the impact on workers and how 
they view new machinery must be carefully considered. Beginning in the rural English midlands with
the machine breaking Luddite movement (Roberts 2017), societal resistance to automated machinery 
replacing manual labour and the threat it poses to livelihoods understandably continues into the 
present day (Jones 2013; Autor 2015). Both positive and negative reactions to the introduction of 
automation have been observed amongst long-term workers in clinical laboratory settings (Thomson 
and McElvania 2019) and it is reasonable to anticipate that similar reactions may arise in research 
laboratories. The outright replacement of researchers by automation is unlikely as they are currently 
categorised as being amongst the lowest risk of being replaced (White, et al. 2019), due to their 
breadth of skills, including planning and creativity (Reeves et al. 2019). However, researchers solely 
employed to perform repetitive manual tasks are more at risk and thus more likely to view 
automation as a threat. Those researchers with a multitude of other protocols and tasks beyond the 
laboratory are more likely to view automation assistance in their day to day roles in a positive 
manner. The short-term contracts that predominate in research will also lessen any hostility to 
automation. Employees who understand that they will be moving on to another position, will see a 
machine as more likely to be a replacement for their replacement rather than a replacement for 
themselves. Although the levels of militancy advocated by the early Luddites may not be repeated, 
laboratory managers who introduce automation will still, like their industrial and clinical 
counterparts, need to be sensitive to workforce reactions, particularly the impact on any long-term 
employees.
4.5 Automation hyperbole
Both vendors of automation equipment and researchers must also be wary of overstating the benefits 
of automation and elevating expectations regarding the impact its introduction will have on future 
work practices. Automation hyperbole and the accompanying benefits is however part of a wider 
trend that is not only restricted to research (Wajcman 2017). Whilst automation can improve protocol
reproducibility and efficiency the individual researcher will, in the majority of cases, still be 
responsible for correctly operating the equipment, with maintenance, quality of input materials, and 
calibration. These are tasks than can require a high level of personal discipline and tenacity. With 
notable exceptions (King et al. 2009; Williams et al. 2015), automation will also be unable to 
undertake the overall experimental design and analysis. Journal publications have a responsibility 
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of their technologies, as well as identifying author conflicts of interests (Miles and Lee 2018). 
Greater awareness of limitations will allow more effective matching of automation solutions with 
laboratory problems and increase the trust between commercial vendors and academic institutions.
5 Laboratory automation obstacles
5.1 Automation is expensive and difficult to justify
The most significant hurdle for PIs wishing to integrate automation systems into their laboratories is, 
unsurprisingly, cost. Commercially available automation equipment is expensive, whilst bespoke 
equipment for individual protocols costlier still. Cell culture is an example of a common, labour-
intensive protocol familiar to generations of researchers. Equipment to automate cell culture is 
available and can save many hours of researcher effort from the process, but is tantalisingly out of 
reach for most laboratories. The cost of these items can be in excess of $1M for a complete process 
system (Storrs 2013) placing them far beyond the reach of the majority of academic laboratories. 
Despite being commercially available for over 18 years (Kempner and Felder 2002) they remain a 
rare sight in research environments but are used in high volume cell-banking organisations (Wrigley 
et al. 2014; Daniszewski et al. 2018; Archibald et al. 2016).
The development of automation equipment can be a time-consuming and expensive process. Initial 
rounds of iterative conceptual and prototype design and testing are followed by final design, build, 
and commissioning phases. Coordination is needed from a variety of disciplines including 
mechanical, electrical and software engineers alongside close collaboration with the end user. Most 
important for all automation projects however, is a source of capital investment. Industrial investment
in automation is matched to business cases in which increasing confidence in the product and the 
associated income from projected sales is used to justify upfront capital expenditure. However, an 
academic principal investigator seeking to invest in automation for their laboratory is confronted by a
different set of challenges. When compared to industrial and commercial organisations, a research 
laboratory’s output or success rate cannot be measured in using the same readily quantifiable metric 
of profit. Indeed, academic research output has long been a difficult entity to define both for 
individual researchers (Klaus and Alamo 2018) and laboratories (Abramo and D’Angelo 2014; 
Kreiman and Maunsell 2011). It is therefore more difficult to construct a ‘business’ case when 
seeking funding for laboratory automation equipment. A factory manager is able to justify a new item
of automation based upon the argument that whilst it may initially cost X units of currency it will 
increase profits by X+Y units, measured in the same currency (Ceroni 2009). A clinical laboratory 
manager can present a similar case based upon both cost (Archetti et al. 2017; Sarkozi, et al. 2003) 
and the quantifiable output of turnaround time (Hawkins 2007; Archetti et al. 2017). A research 
laboratory manager however, in the same position applying for funding, will have greater difficulty 
in arguing that although the proposed equipment will cost X units of currency it will increase their 
laboratory’s research output by Y vaguely defined research outputs. The ambiguity of research 
success hinders laboratories seeking to invest in automation.
5.2 Research funding structures
The allocation of scientific funding to academic institutions further limits investment in automation. 
Research programs are most frequently funded through externally sourced grants that are applied for 
in a competitive environment, with pre-applied constraints on the amounts available and where these 
funds may be spent. Understandably the majority of funding calls open to scientific laboratories are 
seeking answers to novel scientific questions and not looking to develop items of equipment that are 















































automation when applying for grants, capital expenditure on large equipment, if even permitted, must
be explicitly accounted for before the project starts. Unfortunately, the nature of research means that 
the details of protocols needed for the project are not always available during the early proposal 
phase. Estimating the both the timescales and cost of automation at such an early stage is a difficult 
task for supervisors of biological research laboratories who will have limited experience of budgeting
for automation hardware. The time duration of funding grants also limits the development of 
automation, usually with the maximum being 5 years (Vaesen and Katzav 2017; European 
Commission 2016). Automation strategies for industry are generally greater in duration and aligned 
to the anticipated lifecycle of the product, frequently extending into decades. In the case of 
commercialising a novel pharmaceutical product or medical device the automation strategy can be 
aligned to the 20-year exclusivity patent window. Automation expertise acquired over this time can 
then be exploited to maintain a competitive advantage when the window expires. Academic projects 
of a comparable length are rare. The Human Genome Project is one exception, and consequently was 
able to invest and substantially benefit from automation (Meldrum 2000). However, long-term, 
project specific funding stability is rarely available to most academic principal investigators, limiting 
automation investment. 
Short-term research funding also places a limit on the individual researcher’s ability to develop 
automation. Hands-on researchers are best placed to determine which elements of their protocols 
would benefit from automation. However, these individuals are typically PhD students or early career
researchers with a time-limited contract or project. Such temporal limitation leaves little room for 
developing an idea for protocol automation into a functional system, particularly with specific 
scientific targets attached to the grant scheme funding their project. Short duration research positions 
reduce not only the time available to develop novel automated laboratory equipment but also the 
motivation for doing so. On completion, a researcher is likely to move on to a new laboratory 
contract or a career beyond academia (van der Weijden et al. 2016). Researchers are therefore 
unlikely to experience any of the long-term benefits from planning automation. The cumulative effect
of short-term, competitive grant allocations and transient researchers creates an environment unsuited
to the long-term financial investment required for laboratory automation development.
A limited number of large grant funded projects have been successful in devising automation 
strategies and equipment, although often with a focus on industrial scale systems for clinical 
translation rather than research laboratories. One area that seen recent attention is the aforementioned
development of high-volume manufacturing solutions for the production of Mesenchymal and 
Induced Pluripotent Stem Cells to meet anticipated future clinical demand (Rafiq et al. 2016; Jossen 
et al. 2018; Panchalingam et al. 2015; Ochs et al. 2017; Marx et al. 2013). It is hoped that technology
developed in these programs will, in the future, trickle down into more affordable systems that can be
exploited by smaller research laboratories.
5.3 Stifled commercial development of new laboratory automation
Financial challenges also hinder those commercial organisations seeking to develop laboratory 
automation equipment. Industrial automation design and development is often a bespoke, 
collaborative arrangement for a particular challenge. A manufacturer will approach one or more 
automation developers to design a manufacturing system for their product. In this scenario the 
manufacturer is usually a much larger organisation with abundant reserves of capital and will also 
carry the majority of the risk should the product not sell as well as expected. To aid in mitigating this 
risk they are able to utilise their marketing, sales and distribution expertise within their particular 
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An automation developer may wish to partner with an academic research laboratory. However, as 
previously detailed, in such an arrangement the laboratory will be unable to operate as a cash-rich 
development partner unless a substantial funding grant can be obtained. The automation developer 
must therefore carry the risk that the equipment will not be commercially successful and assume the 
role of marketing and selling the product to the wider research community. Biological laboratories 
are best placed to identify where certain processes would benefit from automation, but don’t have the
financial resources or expertise to develop these systems themselves. Automation companies, whilst 
having the capable expertise to develop automation equipment will be reluctant to pursue such a 
business strategy requiring up-front investment to develop a product for customers widely 
acknowledged to have little disposable capital. 
Small-to medium-sized automation companies have often been most successful at innovative 
development of laboratory equipment, funded through grant schemes in cooperation with an 
academic institution or external venture capital funding. Examples include benchtop pipetting 
systems from Andrew Alliance and OpenTrons and Labman automation’s formulation engine. 
Access to joint research grants and funding schemes can encourage the development of novel 
automation solutions by increasing industrial and academic collaboration whilst also reducing the 
risk the commercial risk that developers are exposed to.
5.4 Laboratory space
Alongside the financial investment required for automation researchers must also find physical 
laboratory space for new equipment, incurring a footprint cost (Wong et al. 2018; Moutsatsou et al. 
2019). The size and mass of many automation items means that it is not always practical or safe to 
tidy the item away and store it when it is not required. Laboratory space is often at a premium in 
many research institutions with territorial researchers often coming into conflict over the allocation of
it (Adams 2004). A bench occupied by equipment is also an area that could be otherwise be utilised 
by productive researchers. The requirement for some laboratories to operate as a dual research and 
teaching environment further constrains the available space. It may also not be possible for 
automation to totally replace more manual based equipment and space in laboratories, with room 
required for both. The need to maintain cell culture hoods for teaching is one example. Developers of
laboratory of automation have attempted to minimise the footprint of their machinery through 
innovative reworkings of traditional laboratory procedures. The use of hollow fibre arrays (Russell et
al. 2018) and multi-axis liquid and labware manipulation (Kato et al. 2010) are examples of compact 
automated adherent cell culture systems. Spatial constraints may push future bench-based laboratory 
automation towards an architectural style resembling inner city skyscrapers.
5.5 Protocol variation and usage
The very nature of bioresearch involves the design and implementation of protocols aimed at the 
determining answers to novel research questions. In pursuit of these targets, researchers will devise 
new protocols or substantially modify existing ones to suit their needs. Recurring cycles of method 
generation and evolution within the research laboratory create a high-level of protocol variation that 
is not always easily automated. Matching commercially available automation equipment to these 
requirements is often not a feasible option with fixed componentry and locked-in software frequently 
being the limiting factors. Automated cell culture is an example where the available systems can be 
insufficiently flexible to accommodate the specific cell culture requirements of an individual 
laboratory (Crombie et al. 2017), with some requiring a broad range of cell culture types and others 
having more focussed needs. A high level of experimental process variation is therefore more likely 
















































financial cost. Clinical laboratories, by comparison, have a greater level of consistency across 
protocols both within individual laboratories and across institutions, contributing to the widespread 
implementation of automated systems. High process variability is also cited as one of the major 
challenges for integrating automation into existing industrial environments (Frohm et al. 2006) and is
necessary when adapting to changing market conditions (Froschauer et al. 2008). Across laboratory 
protocols there are process steps that are common, and it these where commercially available systems
are more likely to be of assistance to the individual researcher. Liquid handling, through the 
manipulation of pipettes and receptacles is a one example ubiquitous to a range of molecular biology 
protocols, with a growing number of competing vendors offering more affordable and adaptable 
automation options (Barthels et al. 2020). 
How frequently a protocol is likely to be used over time is also a key factor when considering 
automation. A protocol developed for a specific project may only be used in a single laboratory for a 
short period, negating the long-term benefits that automation could provide. On occasion a researcher
may find that their new protocol becomes widely adopted for an extended period in their own 
laboratory, and possibly throughout other laboratories too. In this scenario automation becomes a 
more attractive option and is not always driven by the original founding laboratory. Sequencing, is 
one example where the initial manual protocol developed by Sanger and colleagues (Sanger et al. 
1977) was eventually automated by researchers at different institutions (García-Sancho 2007).
5.6 Labware and consumables
Automation equipment operates most effectively when input materials or consumables are 
standardised. In the case of standard shaped labware this allows non-adaptive, rigid automation 
components such as grippers to gain full custody of the device, allowing greater accuracy of 
placement and potentially faster actuations. Currently there remains a large amount of variation in 
labware not only between research laboratories but also within the same laboratory. The variant a 
researcher uses can change frequently based upon cost, availability or personal preference. 
Disposable plastics are an example where different manufacturers produce products that are, from an 
experimental, viewpoint functionally identical but with variations in the products dimensions and 
materials. The justification for these variants maybe a small improvement in handling, or simply to 
circumvent intellectual property assigned to a competing product. These present a significant 
challenge to automated handling equipment where even small variations, that are unnoticeable when 
handled manually, can render an automated system using non-adaptive handling elements useless. 
Clinical laboratories negate this issue by utilising standardised plastics for sample collections that can
then be more readily processed autonomously. The recent advent of soft robotics may provide 
solutions to these challenges where rigid handling systems are replaced with pliable, adaptive designs
sometimes based upon biomimetic examples (Noel and Hu 2018). 
A counterstrategy to labware variation has emerged from commercial developers of automation. 
Unfortunately, the solution is often combined with a sales strategy aimed at securing a continuous 
revenue stream following the sale of the initial capital equipment. Commercially available systems 
are frequently designed in a fashion such that automation systems can only operate with specific 
consumables, available for purchase from themselves or a licensed distributor (Moutsatsou et al. 
2019; Huggett et al. 2009). Examples include the pipette tips for the Opentrons and Tecan EVO 
liquid dispensing systems, array tape for Douglas Scientific’s IntelliQube PCR system, purification 
cards for Invitrogens benchpro and spin kits for Qiagens Qiacube system. A laboratory binding 
themselves to a single consumable supplier has little or no guarantee of future price stability or even 
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vendor, supply chain is considered a very unwise strategy in a commercial context but is a 
worryingly frequent arrangement for automation equipment available to research laboratories.
There are two competing forces for labware standardisation; top-down and bottom up pressure, 
outlined in figure 3. Top-down pressure, as described above, is where commercial automation 
organisations seek to dominate a section of the market by forcing users to purchase specific labware 
through the sale of inflexible hardware. Bottom-up pressure acts in the opposite direction, when 
manufacturers of labware and laboratories slowly gravitate towards one standard form that 
automation developers are then forced to adopt. An example where bottom-up pressure has 
succeeded is in the largely standardised external dimensions of well plates, the ANSI/SLAS standard 
(Society for Laboratory Automation and Screening 2011), that has enabled automation of microscopy
and plate reading procedures (McClymont and Freemont 2017). The range of automation equipment 
available for standard well plates is correspondingly larger, increasing competition, reducing running 
costs and making automation more affordable. There is likely to be a reciprocal benefit for labware 
manufacturers too, with an associated increase in demand for consumables. More instances of 
labware standardisation would allow a wider range of protocols to be automated.
5.7 Environment impact
The environmental impact that an item of equipment can have throughout its entire lifespan, from 
manufacture, to usage, to end-of-life disposal and recycling is an important consideration for many 
research institutions. A particular concern for laboratories is the rate at which automation consumes 
disposable plastics. Research institutions produce a large amount of plastic waste, estimated at 5.5 
million tonnes annually (Urbina et al. 2015), primarily to avoid contamination between samples. 
Commitments to minimising their use are part of a growing trend where laboratories aim to switch to 
recyclable or reusable alternatives (Bistulfi 2013; Krause et al. 2020). Automation designed around 
the same single-use plastic principle can generate even greater volumes of waste than human 
operators, due to higher experimental throughputs (Howes 2019). These designs are incompatible 
with research organisations who are committed to minimising their environmental impact. The 
consideration given to environmental concerns is currently very low or non-existent in many 
commercially available laboratory automation systems. An exception is Grenova’s pipette washing 
systems (Safavi and Anderson 2019) that can be integrated into existing automated liquid dispensing 
units. It is hoped that this type of equipment represents an emerging category of environmentally 
focused automation that will become ever more important to laboratories in the future.
5.8 Culture
There exists a fundamental culture difference between an academic research laboratory and the 
industrial workplace environment, that can inhibit investment in automation. It is hoped that the 
majority of principal investigators view their laboratory as a platform for staff and students to 
increase their skills and experience before they move onwards in their careers. This is a crucial 
“people” output that accompanies the research output of a laboratory usually measured in scientific 
discoveries and publications. Although many companies also place a high-value on workforce 
upskilling their focus is primarily on profit and not on being a training institution to allow employee 
progression elsewhere. Consequently, many will favour investment in equipment over staff if a 
business case can be made (Rampell 2011). An academic principal investigator however, is likely to 
preferentially invest in additional people rather than equipment, with funding schemes frequently 
weighted this way too. Money spent on a large item of automation equipment could, for example, pay
for several post-doctoral researchers or fund multiple PhD projects. In the context of automation this 
















































The availability and culture of undergraduate labour may also be inhibiting investment in laboratory 
automation. Undergraduates working in laboratories contribute by performing experiments that can 
generate preliminary data for grant applications or for publications. The benefits to the student reside 
in the acquisition of experience and skills that can enhance their employability prospects upon 
completion of their studies (Seeling and Choudhary 2016). This reciprocal arrangement and the high 
availability of undergraduates provides a means for carrying out labour intensive laboratory tasks. 
Not all principal investigators will view this relationship in such a cold manner, and will 
considerately assign duties that can generate useful data whilst simultaneously teaching students both
the basics and realities of research. Unfortunately, there is evidence that some less altruistic 
supervisors do assign undergraduates to tasks that require a high degree of repetition (Hayward et al. 
2017). These are likely to be precisely the type of tasks where automation can be effectively applied.
6 The laboratory automation interim technology gap
It is interesting to compare the relatively recent development of manual labour-saving laboratory 
automation equipment with other older, more mature automation processes. Here we refer to 
equipment that replaces manual human manipulation rather than machinery that performs operations 
operators are physically incapable of executing, such as centrifuging. Taking the millennia-old 
example of sewing, with just a needle, thread and cloth it is possible, given time, for a skilled human 
operator to create a garment. Equally the same items can be completely mechanised with expensive, 
high-level automation equipment and the garment produced with no human input necessary beyond 
the need to turn the machine on. Comparing with the laboratory process of cell culture which 
requires, media, pipettes, labware and some starting cells a skilled operator can also, given time, 
passage cells and create a sub-culture for experimentation. Again, the same output can also be 
produced using an entirely automated, costly, high-level system, with minimal operator input. 
However, in the case of needlework there exists a range of lower cost interim labour-saving 
automation options between these two extremes, such as motor driven stitching machinery, or 
manually powered mechanisms, exemplified in the Singer sewing machine (McLoughlin and 
Mitchell 2013). This is not currently the case for cell culture, there are no examples of commercially 
available low-cost machinery (Figure 4).
Interim automation can arise in several scenarios. More commonly it occurs incrementally over time, 
as technological advances permit a shift from simple to complex machinery. Alternatively, on 
occasion a high-end complex automation system may be simplified due to new demands, such as an 
economic demand for cheaper equipment. For many laboratory automation processes there has been 
a rapid leap from simple to complex with, as yet, little or no development of lower cost automation 
technology. We believe this is due in part to the reasonable desire for academic laboratories and 
companies to be seen to be developing equipment at the forefront of technology. In simple terms, 
low-cost interim automation that removes some but not all of the manual labour from a protocol is 
not fashionable enough. It is unlikely to lead to a prestigious journal publication and, for commercial 
organisations, will not lead to financial rewards, with likely low sales volumes and low profit 
margins. There are therefore few incentives for academic and commercial automation developers to 
design such equipment.
7 In-house laboratory automation
Despite the hurdles facing researchers wishing to automate elements of their experimental 
procedures, there are many examples where laboratory automation development is carried out “in-
house”, without the assistance of a commercial partner or a large automation dedicated funding grant.
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automation but find themselves restricted financially and functionally by commercially available 
options (Pilizota and Yang 2018). A range of ingenious methods have been developed to build low-
cost automation solutions, including the integration of Lego into microscopy automation (Almada et 
al. 2019), microfluidics for DNA assembly (Shih et al. 2015) and rapid synthesis and testing of small 
molecule libraries (Baranczak et al. 2017). Laboratories with novel protocols that are nearly but not 
quite suited to existing automation equipment have been able to successfully upgrade commercially 
available systems for their specific needs (Zhang et al. 2016; McGraw et al. 2014; Konczal and Gray 
2017; Richter et al. 2015; Crombie et al. 2017). Repurposing existing equipment in this fashion either
through software or hardware modification is a cost-and time-efficient method of obtaining higher 
levels of protocol automation without the arduous task of designing and building an entirely novel 
system. The number of automation development tools, components and virtual training options 
available to research laboratories continues to broaden, increasing their capability to develop low-
cost solutions to labour intensive processes. The advent of affordable 3D printing modalities (Capel 
et al. 2018; Zluhan et al. 2016; R. Jones et al. 2011), off the shelf actuators and readily programable 
microcontrollers (Kim et al. 2015; Wong et al. 2018; Mabbott 2014) has given research laboratories 
the ability to produce componentry that can then be assembled, controlled and automated all for a 
relatively low cost (Barthels et al. 2020; Courtemanche et al. 2018; Needs et al. 2019). Open source 
designs and software have an important enabling effect for researchers who may not have 
engineering or programming expertise. Researchers are also able to exploit the growing market for 
second hand laboratory automation equipment (Zluhan et al. 2016), a case of one lab’s trash is 
another labs treasure. Developing automation internally, whilst often cheaper, and potentially a more 
rewarding and enjoyable process (Pilizota and Yang 2018) can however require a substantial 
investment in time (May 2019). That laboratories are frequently forced into developing their own 
systems is an indication of the paucity of commercially available options. Existing automation 
developers see an insufficient market for providing their services and expertise to develop bespoke 
items for individual laboratories and will be justifiably reluctant to provide open source solutions that
may compromise their intellectual property.
8 Remedies
Increasing the quantity and quality of laboratory automation within the research laboratory will 
require a concerted effort from funders, research institutions, automation developers and researchers 
themselves. The desire to automate elements of laboratory protocols exists. Researchers and their 
governmental funders (Reeves et al. 2019) collectively recognise that mechanisation can improve 
reproducibility and efficiency. When attempting to develop laboratory automation three interrelated 
components are needed for success. Connecting researchers with automation needs to automation 
engineers, financing the resulting collaboration, and ensuring the resulting design meets the needs.
8.1 Collaboration
Encouraging academic researchers to engage and collaborate with industrial organisations has been a 
long-standing objective for their host institutions. Such joint enterprises are hindered by the 
significant differences in culture and attitudes to one another (Berman 2008) which are in part due to 
each partner having different timescales and expectations from projects. Academics build projects 
slowly through the funding stages and ultimately desire experimental data that can be packaged into 
publications. Industry often likes to move more quickly and would like intellectual property that can 
be reconstituted into a commercial opportunity (Lynch 2016). Contrary to widespread belief these 
viewpoints are, however, not always the most prominent motivations for collaboration, with altruistic
















































Automation engineers and life science researchers operate in markedly different disciplines and in 
different work environments, rarely occupying the same space to share problems and ideas. Events 
where these disparate groups can be brought together would allow new ideas and projects to develop,
in a similar fashion to academic conferences encouraging collaboration between different 
laboratories. Automation engagement events that feature all levels of employees from both sides of 
the divide would have the greatest effect. Interaction between industrial managers and academic 
supervisors as well as researchers who are researching and engineers who are engineering could 
allow the development of solutions to everyday automation challenges in the laboratory.
Collaboration can also be an internal academic arrangement. Life science laboratories often have a 
source of automation engineering expertise within their own institution in the form of engineering 
faculties. Both disciplines could benefit from increased interaction and discussion around laboratory 
automation, with examples of collaborating biomedicine and engineering departments producing 
innovative automated equipment (Kane et al. 2019; Kato et al. 2010). Collaboration at an educational
level can be beneficial too. Allowing undergraduate engineering students to undertake projects based 
upon automating a protocol within a laboratory would provide the host laboratory with designs and 
automation aids. Interdepartmental, interdisciplinary collaborations can bring benefits for students 
too, providing real world problems to develop their skills and the opportunity to apply theoretical 
knowledge (Wilson and Zamberlan 2012).  
More varied career paths that allow employees with experience of industry-based automation to work
in research environments can also develop new ideas that lead to mechanised laboratory equipment.  
Academic and industrial career paths diverge at early career stage and rarely reconnect. The majority 
of professional individuals progress from an academic institution into an industrial or commercial 
organisation. Researchers typically remain within a university environment accruing the required 
qualifications and experience as their career progresses. Reverse flow of employees, where an 
individual moves from industry to academia is less common (Bonner 2006). Encouraging a greater 
level of employees with experience of automation to work within life science laboratories will 
promote an exchange of ideas that can lead to experimental mechanisation. Such employee 
exchanges need not be permanent and can be sabbatical-style placements targeted at a specific 
project. The Knowledge Transfer Partnership is one successful long-running academic-industry 
exchange scheme in the authors host country that allows an employee to concurrently work on a 
project at both an academic and industrial organisation (Howlett 2010). These types of employee 
arrangements have a further benefit in deepening the relationships between Universities and 
industrial organisations. Academic institutions that can successfully foster relationships with 
industrial partners can reap substantial rewards not only in the form of publications and possible 
financial licencing agreements but greater reproducibility too (Edwards 2016). In a notable success 
story, automated sequencing technology, now the mainstay of genetic research, was successfully 
developed at Caltech, a research organisation with strong links to industry (García-Sancho 2007). 
Ultimately though any collaboration, regardless of the method of inception, is unlikely to succeed or 
even be embarked upon unless both partners are confident that they have the financial resources to 
proceed.
8.2 Funding
Greater implementation of automation can bestow benefits to funding organisations. Devoting 
financial resources towards automation engineering may seem paradoxical where the long-term 
objectives are targeted towards developing therapeutic interventions for biological diseases. 
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organisations. Automation is a critical component in driving upwards the reproducibility of 
disseminated research (Winder 2019). In addition, as research confidence increases in a particular 
therapy consideration will eventually need to shift towards how the technology can be produced in 
sufficient quantities and at an affordable price so that it is available to the greatest range of patients. 
As previously discussed, including automation at earlier stage in the development process can help in
attaining these goals, easing the transition from the experimentation phase to clinical usage. 
Competitive schemes, where funds are specifically are made available for developing laboratory 
automation would be beneficial in bridging the distance between the lab bench and the bedside.
Automation can provide benefits too for governments funding academic institutions. Increasing the 
level of automation across workplaces is acknowledged as strategy for economic progress (Reeves et 
al. 2019; Velásquez et al. 2009) with research laboratories being no exception. Access to higher 
levels of automation increases the output of research laboratories that exist in publicly funded 
institutions. Any associated automation dividend will also require appropriately skilled technical staff
to maintain, operate and enhance laboratory equipment. A greater range of dedicated grant schemes 
specifically targeted at developing laboratory automation will, in the long-term, increase the 
effectiveness of all research funding.
8.3 Laboratory automation design
Improvements can be made in automation design, how it is implemented in laboratories and the range
of available automations options. A large amount of laboratory automation is based upon an 
anthropomorphic design framework that mimics human movement. Expensive laboratory equipment 
frequently features an over reliance on robotics to manipulate tooling, reagents and labware in a 
similar manner to how researchers would themselves. These types of designs can present as being 
visually high-tech and impressive and there is indeed an advantage to machinery that presents as 
more human-like in that it is more likely to be trusted by human operators (de Visser et al. 2016). 
Unfortunately for many applications these designs are not always the most efficient means for 
automating a laboratory protocol. Robotic actuators featuring multiple axes and large operating 
envelopes also require even larger guarding enclosures and correspondingly complex control systems
(Yachie and Natsume 2017). These design attributes render such equipment spatially and 
economically unsuitable for the majority of research laboratories. McClymont and Freemont provide 
an example where an assay requiring liquid handling can be more effectively processed and 
multiplexed with tooling that is not based upon an anthropomorphic design (McClymont and 
Freemont 2017). Hollow fibre cell culture systems are further examples of automation systems that 
have successfully eschewed more traditional anthropomorphic designs (Eghbali et al. 2016). 
Designing for flexibility is also an important factor for laboratories where there is a high level of 
protocol variation. Laboratory automations systems designs that anticipate future scientific 
developments and allow for subsequent adaptation will be less likely to become prematurely obsolete
and thus more valuable to research laboratories. Machinery based upon modular based design is one 
approach to a flexible system. Modular automation systems can allow selective matching of 
automation to the protocol requirements, minimising the purchase of redundant features, and also 
providing the option for future upgrades should it be needed. There are indications that laboratory 
automation developers are becoming more aware of the need for flexibility. The ongoing 
development of technology such as Formulatrix’s rover system is one example where microwell 
plates are autonomously transferred between processing modules in a novel reworking of the robotic 















































The capability for an automation system to be modified without specialist engineering knowledge is 
desirable too. Allowing researchers to automate a wider range of process steps without the need for 
time consuming and expensive tooling redesign or extensive software reprogramming. An interesting
extension of the modular design approach is to unify existing automation equipment so that it capable
of performing the desired protocol in one continuous process stream. The recent development of 
software by the company Synthace that is capable of communicating and linking robotics from 
different manufacturers is one promising system for laboratories requiring highly flexible systems 
(Jessop-Fabre and Sonnenschein 2019; Sadowski et al. 2016).
To reduce the manual labour burden on laboratory research staff and students there is a need for a 
broader range of automation equipment. These designs should target the identified gap in labour 
saving automation with a focus on reducing price and footprint. In this regard employing multi axis 
robotics may not be the most optimal design solution and developers should be prepared to explore 
more cost-effective, low-tech routes to protocol automation, even if seems like a less fashionable 
option.
9 The future of laboratory automation
It is with a certain degree of trepidation that we follow in the footsteps of others and attempt to 
predict the future of laboratory automation. The life science research laboratory of the future will 
undoubtably feature more automation equipment. How quickly automation is adopted will in all 
probability be slower than many would like and haphazard, with some fields being more suitable than
others. Many of the obstacles to laboratory automation ingress we have described are long-standing 
and hardwired into the working practices of academic research. In particular financial hurdles faced 
by individual principal investigators are unlikely to be resolved and overcome in the immediate 
future. Bespoke, high-level automation solutions will remain beyond the reach of all but the most 
monied laboratories for a considerable time. Greater progress can be anticipated in the design and 
price of lower-level automation equipment. It is reasonable to assume that like other technologies 
laboratory automation will continue to mature with falling prices and more user centred designs. 
Hopefully incorporating more flexibility in response to consumer demand. In part this progression is 
already underway, with promising releases of low-cost liquid handling platforms and ongoing 
development of modular systems. The demand from research laboratories for automation that seeks 
to limit its impact on the environment will grow considerably and it is hoped that developers will 
create and adapt their designs to meet this need. Life science researchers will also continue to 
develop their own homemade laboratory automation and repurpose existing equipment, encouraging 
other laboratories to also take the leap into engineering. We predict that the second hand market will 
become an important resource for those choosing this route to automation.
Access to pooled resource, high-level, automation in the form of academic biofoundries is increasing 
and will continue to do so with expansion of existing facilities and the foundation of new ones. The 
outsourcing of protocols to commercial cloud laboratories has been predicted to become 
commonplace for a huge range of life science laboratories. From the perspective of the lab bench we 
are more circumspect in regards to the impact these organisations will have on day to day 
experimental research, with experimental range and flexibility key issues. Ultimately however, the 
marketplace laws of supply and demand will dictate the success rate of these enterprises.
An appreciation of the limitations of automation both generally and for items of specific equipment is
needed from academic, commercial and funding organisations and individuals. Of all the limitations 
discussed in this review we wish to particularly highlight the danger of innovation inhibition. 
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be retained if research is to retain a high degree of novelty. Ensuring that automation remains 
compatible with the curiously minded researcher will be a significant challenge for our field in the 
future.
In response to automation ingress the skills of life science researchers will need to adapt. The 
presence of more automation equipment will require more engineering type-skills to ensure correct 
equipment operation and implementation of protocols, along with a working knowledge of the 
biology under experimentation. Researchers will therefore need both biology “wet” skills and “dry” 
automation skills; such people have been imaginatively titled amphibious researchers by 
Mellingwood (Mellingwood 2018). It is therefore likely that automation will spawn a new generation
of researchers with a range of interdisciplinary skills.
In summary, automation in life science laboratories lags behind its industrial and clinical counterparts
due to an array of inhibiting factors, including financial, spatial and cultural challenges. Those who 
are able to surmount these barriers and integrate automation into their everyday protocols can reap 
significant reproducibility and efficiency benefits. It is essential that future laboratory automation 
systems are designed for flexibility to permit adaptation for changing laboratory needs and prevent 
the stifling of protocol innovation. A wider range of affordable bench top and remote automation 
options will steadily increase the ubiquity of mechanisation in life science research. Such progressive
adoption of automation will emphasise the already growing interdisciplinary nature of research 
further blurring the boundary between science and engineering.
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Figure 1 - Prevalence of terms “automation” or “automated” and “robot” or “robotic” within the 
titles of PubMed articles per year over the period 1970 to 2019.
Figure 2 – Benefits and limitations of research laboratory automation.
Figure 3 – Top-down and bottom-up consumable adoption pressures. Top-down pressure occurs 
when an automation developer imposes a consumable on laboratories through tooling specific design.
Bottom-up pressure acts in the reverse direction with laboratories and automation suppliers 
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Figure 4 - Comparison of available labour-saving automation options for the manual intensive 
processes of sewing and cell culture. Sewing has a range of interim automation options up to fully 
autonomous systems. Cell culture by contrast has only high-level automation equipment and no 
interim low-cost analogues to replace or augment manual labour.
Table 1 - Automation levels (Frohm et al. 2008) with example laboratory automation equipment and 
an indicative cost range.
Automation
level
Description Biology research lab example Indicative cost
1
Totally manual - Totally manual
work, no tools are used, only the
users own muscle power. E.g.
The users own muscle power
Glass washing. £0
2
Static hand tool - Manual work
with support of static tool. E.g.
Screwdriver
Dissection scalpel £10 to £30
3
Flexible hand tool - Manual work
with support of flexible tool. E.g.
Adjustable spanner
Pipette £100 to £200
4
Automated hand tool - Manual
work with support of automated






Automatic work by machine that is
designed for a specific task. E.g.
Lathe






Automatic work by machine that






Totally automatic - Totally
automatic work, the machine
solve all deviations or problems
that occur by itself. E.g.
Autonomous systems
Automated cell culture system,
bespoke laboratory equipment
E.g: Labman Formulation
engine.
£100,000 to
£1,000,000
1187
1188
1189
1190
1191
1192
1193
1194
